Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients | Zendy

Raj Kumar Badam | Zendy; Jyotsna Suram | Zendy; Dara Balaji Gandhi Babu | Zendy; Shefali Waghray | Zendy; Rahul Marshal Vaddeswarapu | Zendy; Sharath Chandra Bontha | Zendy; Reddy Lavanya | Zendy; Sudheer Kanth | Zendy

Open Access

Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients

Author(s) -

Raj Kumar Badam,

Jyotsna Suram,

Dara Balaji Gandhi Babu,

Shefali Waghray,

Rahul Marshal Vaddeswarapu,

Sharath Chandra Bontha,

Reddy Lavanya,

Sudheer Kanth

Publication year - 2016

Publication title -

journal of clinical and diagnostic research

Language(s) - English

Resource type - Journals

eISSN - 2249-782X

pISSN - 0973-709X

DOI - 10.7860/jcdr/2016/16091.7121

Subject(s) - medicine , thyroid , scintigraphy , salivary gland , radiation therapy , radioactive iodine , nuclear medicine , iodine , thyroidectomy , submandibular gland , carcinoma , urology , pathology , chemistry , organic chemistry

Thyroid carcinoma represents less than 1% of all cancers. The first line of treatment for thyroid cancer is partial/total thyroidectomy. High-dose Iodine(131) therapy using Iodine radioisotopes is commonly used in patients with well differentiated thyroid carcinoma after total thyroidectomy. In this process, the non-thyroidal tissues, such as, salivary gland, stomach and breast tissues also take up radioactive iodine. Salivary gland scintigraphy is widely accepted as a sensitive and valid method for evaluation of salivary gland dysfunction after Radioactive Iodine(131) Therapy (RIT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research